Magnetic resonance imaging of breast cancer

Researchers report the use of hyperpolarized 13C magnetic resonance imaging (HP 13C-MRI) to monitor the conversion of 13C-labeled pyruvate into lactate in seven breast cancer patients, ages 49-76 years, finding lactate formation to be associated with higher tumor grade and with expression of the hypoxia indicator HIF1α and the pyruvate transporter MCT1 and suggesting the feasibility of HP 13C-MRI for noninvasive characterization and monitoring of breast tumors.

###

Article #19-13841: “Imaging breast cancer using hyperpolarized carbon-13 MRI,” by Ferdia A. Gallagher et al.

MEDIA CONTACT: Ferdia A. Gallagher, University of Cambridge and Cancer Research UK, UNITED KINGDOM; tel: +44-1223-746438; e-mail: <

[email protected]

>; Ramona Woitek, University of Cambridge, UNITED KINGDOM; tel: +44-751-752-6738; e-mail: <

[email protected]

>; Kevin M. Brindle, University of Cambridge and Cancer Research UK, UNITED KINGDOM; tel: +44-1223-769500; e-mail: <

[email protected]

>

This part of information is sourced from https://www.eurekalert.org/pub_releases/2020-01/potn-mri011520.php

Ferdia A. Gallagher
44-122-374-6438
[email protected]

withyou android app

Leave a Reply

Your email address will not be published.